Benzinga
Published October 21, 2026
Enveric Biosciences Reports Favorable Preclinical Results for Non-Hallucinogenic ... - Benzinga
Read the full story at Benzinga
Trump administration eyes ibogaine research for PTSD and addiction, despite safety concerns and Schedule I classification. 3 min read. Read this.
Surfaced by this Google Alert
- Ibogaine